Taligen Therapeutics Inc. closed a tranched Series B financing round that eventually could bring the company as much as $65 million. Woodruff Emlen, co-founder, president and CEO of Aurora, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results